News

Filter

Current filters:

Synflorix

Pfizer and GSK to compete for $120 million Russian pneumococcal vaccine contract

Pfizer and GSK to compete for $120 million Russian pneumococcal vaccine contract

08-10-2014

US pharma giant Pfizer and UK peer GlaxoSmithKline plan to compete for the 3.47 billion-rouble ($120…

GlaxoSmithKlineMarkets & MarketingPfizerPharmaceuticalPrevenarRussiaSynflorixVaccines

GSK’s Synflorix gets additional indication in Europe

GSK’s Synflorix gets additional indication in Europe

05-12-2013

The European Commission has granted marketing authorization for an additional indication for UK pharma…

Antibiotics and Infectious diseasesEuropeGlaxoSmithKlinePharmaceuticalRegulationSynflorix

GSK's Synflorix to be used for GAVI pneumococcal vaccines program in Pakistan

10-10-2012

World's largest pneumococcal mass vaccination program is expected to protect up to 4.8 million children…

Asia-PacificGlaxoSmithKlineHealthcareMarkets & MarketingPharmaceuticalSynflorixVaccines

News briefs from Threshold, Merck KGaA and GSK

18-09-2012

US biotech firm Threshold Pharmaceuticals (Nasdaq: THLD) said yesterday that data from a Phase IIb trial…

BiotechnologyErbituxEuropeGlaxoSmithKlineMerck KGaAMerck SeronoOncologyPharmaceuticalRegulationResearchSynflorixTH-302Threshold PharmaceuticalsVaccines

GlaxoSmithKline challenges Argentina court ruling

12-01-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) says it disagrees with the recent court ruling in favor of…

FinancialGlaxoSmithKlineLegalPharmaceuticalSouth AmericaSynflorixVaccines

Back to top